| Income statement (USD) | FY 2026 ended Jun 30, 2026 | FY 2025 ended Jun 30, 2025 | FY 2024 ended Jun 30, 2024 | FY 2024 ended Jun 30, 2023 |
|---|---|---|---|---|
| Revenue | 0 | 86.0K | 12.0K | |
| Research and development | 5.21M | 10.75M | 12.88M | 6.31M |
| Operating expenses | 23.03M | 23.88M | 30.05M | 49.67M |
| Operating income | -23.03M | -23.79M | -30.04M | -49.67M |
| EBITDA | -22.79M | -23.54M | -29.94M | -49.58M |
| Interest expense | 0 | 303.0K | ||
| Income before tax | -19.30M | -46.88M | -18.43M | -48.81M |
| Income tax | 0 | 0 | 30.0K | |
| Net income | -19.30M | -46.88M | -18.46M | -48.81M |
| EPS | -1.66 | -40.82 | -1.15 | -3.32 |
| EPS (diluted) | -1.66 | -40.82 | -1.15 | -3.32 |
| Diluted shares | 11.66M | 1.15M | 16.16M | 15.38M |
From Incannex Healthcare Inc.'s 10-K and 10-Q filings with the SEC. Fiscal years are the company's own, so they may not match the calendar. A blank cell means the company did not report that line. New to this? Read income statement or reading a 10-K.
Revenue, earnings, margins and balance sheet trends drawn by TradingView from its own data, so figures can differ slightly from the SEC table above.